Partners Tim Corbett, Joachim Heine, Omar Shah, Mike Pierides, Louise Skinner, Lee Harding and consultant Paul Ranson wrote an article for PharmaTimes Magazine assessing how current market dynamics in the European life sciences have been effected by COVID-19. They discussed data privacy considerations, and the increased prominence of AI and European pharmaceutical regulations.
Read the full PharmaTimes Magazine article >>
Subscription may be required.